Dr Reddys Laboratories:
Angel Broking has maintained a neutral rating on Dr Reddys Laboratories (DRL) in its February 21, 2013 research report. The research firm expects net sales to report a 9.8% CAGR to Rs 11,662cr and adjusted EPS to record a 2.3% CAGR to Rs 92.9 over FY2012-14E.
"DRL reported more or less just-in 3QFY2013 top-line and bottom-line performance. The company's net sales increased by 3.5% yoy (23% adjusted for the base effect). The growth came in on back of 24% yoy (adjusted) in the US and Emerging Markets. On the EBIT margins came in at 15.0% V/s expected 15.8%. Consequently the net profit came in at Rs 363cr, a dip of 29.1%, mostly in line with expectations of Rs 339cr.
NTPC, Power Grid:
Gautam Sinha Roy of Motilal Oswal Securities advised taking long call on NTPC and Power Grid . He feels these stocks could be benefited from the Budget.
Sinha Roy told CNBC-TV18, "If you look at from overall perspective then it is best to stick to high quality defensive names given the volatility that we are seeing in market currently. Not only India but global markets across asset classes we are seeing a lot of volatility. That gives me the cue that we should stick to quality at this time."
Infosys, Reliance, Bharti:
Sudarshan Sukhani of s2analytics.com recommended buying Infosys , Reliance Industries ,Bharti and HUL for next wee. He, however, also advised selling Century Textiles and Colgate Palmolive .
Sukhani told CNBC-TV18, "As a trader I would be taking light positions next week that is rule number one. In front of a big news event volumes should be reduced but that is a question of tactics. Much more important is that I would be willing to go and buy in this market purely as a short-term trade for next week."
SP Tulsian of sptulsian.com advised buying Zee Entertainment . Shares rose 1.88 percent to Rs 219.35 on Friday.
Tulsian told CNBC-TV18, "I am looking to buy Zee Entertainment. The kind of level this stock has held on in spite of the carnage in the recent past, the stock has been holding quite strong at Rs 220. So maybe a gain of about Rs 10-12 in next one week is possible."
DISCLAIMER: GoodReturns provides you with information covering shares, futures and options based on broker's reports as stated on various media. Investors are, however, warned that they should NOT take any buy or sell decision based on these views expressed in the article. Investors should consult their own financial and share advisors before taking purchase or sale decisions. GoodReturns does not take any responsibility for any losses incurred by investors who take their cues from the above article.